Use access key #2 to skip to page content.
$26.00 1.13 (4.54%)
7/8/2008 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

1

Avatar rangercapt (34.86) Submitted: 12/11/06 7:58 PM : Outperform Start Price: $38.58 AMLN Score: -22.38

AMLN is more then just a diabetes treatment. It is going to evetually provide enough information to prevent it from getting worse and may reverse this deadly disease. Other companies are trying to make inhalable insulin when they should be trying to help the body create insulin. I like it to at least take out the old high from it's current level

Report this Post Replies: 0 | Reply

Featured Broker Partners